HULIO
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for HULIO, covering 2020-07-06 to 2026-08-27. Get the full timeline:
Most recent: EMA Authorised: Hulio (adalimumab) — Biosimilar Collaborations Ireland Limited